On these grounds, we argue that not only antigen exposure trajectories but also affinity maturation processes may differ for IgA MM versus IgG MM, further underlining the role of microenvironmental interactions in the pathogenesis of the disease. The gene discussed is CD79A; the disease is Miyoshi myopathy.